Bravehaeart Bio Stock
Braveheart Bio is a clinical-stage biotechnology company that develops precision small-molecule therapies targeting cardiovascular disease. It focuses on advancing a proprietary inhibitor designed to improve heart muscle function and treat hypertrophic cardiomyopathy with a novel mechanism. The company’s core mission is to pioneer next-generation treatments that address underlying heart conditions rather than only symptoms.
Sign up for SecondMarket® to view the market and buy or sell Bravehaeart Bio Stock
Buy + SellBravehaeart Bio Funding
Sign up to gain insights into Bravehaeart Bio funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Financing Round | Date | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Series A | Nov 05, 2025 | 185.00M |
See Bravehaeart Bio Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Bravehaeart Bio Stock Valuation + Share Prices
View real-time Tape D® data on Bravehaeart Bio stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Bravehaeart Bio Management Team
-
CFO
Paul Rickey
-
Chief Development Officer
Michele Anderson
-
President, CEO
Travis Murdoch
Bravehaeart Bio Major Investors
-
Enavate Sciences
-
Andreessen Horowitz
-
OrbiMed Advisors
-
Forbion Capital Partners
-
Frazier Life Sciences Management
Learn More About Bravehaeart Bio Stock
Buy Bravehaeart Bio Stock
01Bravehaeart Bio stock does not trade on public stock exchanges. Bravehaeart Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Bravehaeart Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Bravehaeart Bio Stock
02Bravehaeart Bio Stock does not trade on public stock exchanges. In order to sell Bravehaeart Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Bravehaeart Bio Stock Price
03Bravehaeart Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Bravehaeart Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
Bravehaeart Bio Stock Ticker Symbol
04There is no ticker symbol for Bravehaeart Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Bravehaeart Bio Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Bravehaeart Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Bravehaeart Bio Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Bravehaeart Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Bravehaeart Bio Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Bravehaeart Bio IPO
08Bravehaeart Bio is a private company and has not had an IPO. There is currently no Bravehaeart Bio IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Bravehaeart Bio IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Bravehaeart Bio Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
